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Abstract 
Background: Childhood tuberculosis (TB) is acquired following exposure to an infectious 
TB case, often within the household. We prospectively screened children 6-59 months of age, 
exposed and unexposed to an infectious TB case within the same household, for latent 
tuberculosis infection (LTBI), in Dar es Salaam, Tanzania. 
Methods: We collected medical data and clinical specimens (to evaluate for helminths, TB 
and HIV coinfections) and performed physical examinations at enrollment and at 3-month 
and 6-months follow-up surveys. LTBI was assessed using QuantiFERON (QFT) at 
enrollment and at 3 months.  
Results: In total, 301 children had complete data records (186 with TB exposure and 115 
without known TB exposure). The median age of children was 26 months (range 6-58); 52% 
were females, and 4 were HIV-positive. Eight children (3%) developed TB during the 6-
month follow-up. We found equal proportions of children with LTBI among those with and 
without exposure: 20% (38/186) vs. 20% (23/115) QFT-positive, and 2% (4/186) vs. 4% 
(5/115) indeterminate QFT. QFT conversion rate was 7% (22 children) and reversion 8% (25 
children). Of the TB-exposed children, 72% initiated isoniazid preventive therapy (IPT), but 
61% of parents/caregivers of children with unknown TB exposure and positive QFT refused 
IPT. 
Conclusions: In this high burden TB setting, TB exposure from sources other than the 
household was equally important as household exposure. Nearly one third of eligible children 
did not receive IPT. Evaluation for LTBI in children remains an important strategy for 
controlling TB, but should not be limited to children with documented TB exposure. 
Key words: Children, Interferon-gamma release assay, Latent tuberculosis infection, 
Screening, Isoniazid preventive therapy. 
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INTRODUCTION 
Tuberculosis (TB) continues to claim the lives of infected children younger than 5 years, 
and has been identified among the top 10 causes of death in this age group.
1
 Young children 
typically acquire Mycobacterium tuberculosis infection from an infectious adult with 
pulmonary TB within the same household. Children with latent tuberculosis infection (LTBI) 
are at high risk of progressing to active TB disease within 12 months after infection;
2
 and the 
risk is highest among children whose mothers are index cases.
3, 4
 Contact tracing and 
isoniazid preventive treatment (IPT) are recommended by the World Health Organization 
(WHO) to prevent active TB disease among high-risk populations, including under-5 year-old 
children. However, IPT uptake is a challenge; only 7% of children eligible for IPT received 
medication in 2015 worldwide.
5
 
Despite the WHO’s emphasis on providing TB preventive therapy, contact tracing 
remains a largely neglected part of TB control in high-burden countries due to lack of 
financial and human resources, coupled with the high costs associated with diagnostics and 
contact tracing itself.
6
 High-income countries mostly use interferon-gamma release assay 
(IGRA) for TB contact tracing, which has high specificity for detecting M. tuberculosis 
infection but limited sensitivity, particularly in children.
7
 Most TB programs in low-income 
countries and high TB-incidence rates use tuberculin skin test (TST) instead of IGRA, such 
as the ELISpot-based test (T-SPOT.TB) and the enzyme-linked immunosorbent assay 
(ELISA)-based test QuantiFERON-TB Gold (QFT), that are restricted to research use only in 
these settings.
8-10
 Due to the limitations of IGRAs for the diagnosis of LTBI in children in 
high TB incidence countries, a quantified exposure score was recently proposed to serve as a 
surrogate measure of M. tuberculosis infection, specifically in TB-exposed children.
8, 11
 
In Tanzania, the National TB and Leprosy Control Program (NTLP) reported that 
childhood TB cases constituted 10% of the country’s TB cases in 2004–2012.12 To interrupt 
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transmission of TB and combat the childhood TB epidemic in the country, since 2013, the 
program has been working to improve childhood TB case detection and reporting. However, 
the yield of infection screening, particularly among children without documented TB 
exposure, and the implications for screening strategies in routine settings has not yet been 
investigated.
13
  We conducted a prospective study among children under the age of 5 years 
exposed to infectious pulmonary TB cases in their households and controls from neighboring 
households, to assess the prevalence of LTBI among under-5 year-old children in a high TB 
burden setting in Tanzania, using immunodiagnostic tests and a quantified TB exposure 
score. 
MATERIAL AND METHODS 
Study Setting and Design 
Temeke is one of three districts in Dar es Salaam, the economic capital of Tanzania, with 
an estimated 1.4 million residents. The under-five mortality in Dar es Salaam is 72 per 
100,000.
14
 In 2014, TB prevalence in adults was 270 per 100,000 population in Temeke.
15
 
HIV prevalence among pregnant mothers in the district is estimated to be 6%.
16
  The NTLP 
conducts routine contact tracing of young children by counselling smear-positive adult TB 
cases to bring children under the age of 5 years from their households for symptom-based TB 
screening and IPT if not found to have disease. 
We conducted a prospective study in Temeke district among TB-exposed children, with 
the overarching aim of exploring TB/helminth co-infection, as previously described.
17
 To 
recruit controls, we invited children from neighboring households according to standard 
operating procedures (Supplemental Digital Content 1, http://links.lww.com/INF/D201 
standard operating procedure),
18
 and after asking if there was an adult on TB treatment or 
suspected of having TB in the household. Children were referred to the Reproductive and 
Child Health (RCH) Clinic at Temeke Municipal Hospital (where children under the age of 5 
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years are typically seen) for enrollment and follow-up visits at 3 and 6 months after 
enrollment (Fig., Supplemental Digital Content 1, http://links.lww.com/INF/D201). 
Study Population and Sample Size Consideration 
We invited 398 parents/caregivers of children 6–59 months of age, between October 
2015 and September 2016. Children were included if: (i) their parents/caregiver provided 
written informed consent; (ii) they were 6–59 months of age at the time of enrollment; (iii) 
they resided within Temeke district and would continue to do so in the next 6 months after 
enrollment; and (iv) they lived with a smear-positive adult pulmonary TB case, as diagnosed 
by sputum smear microscopy and culture
19
 (for case children) or came from households 
without documented TB case (for control children) (Text, Supplemental Digital Content 2, 
http://links.lww.com/INF/D202). Children with known TB exposure were recruited within a 
month of the index case starting TB treatment. 
We aimed for a sample size of 300 children 6–59 months of age, with 150 TB-exposed 
and 150 TB-unexposed children. This sample size was estimated to provide a precision of 5% 
in estimating TB infection prevalence, with an error probability of 5%. 
Study Procedures 
At Enrollment: The study clinician collected demographic and socioeconomic 
information and, using a standardized case report form (CRF), evaluated children for the 
following TB signs and symptoms: (i) current cough of any duration; (ii) abnormal fatigue or 
reduced playfulness; (iii) documented weight loss or failure to thrive in the past 3 months; 
(iv) axillary temperature >37.5 °C; (v) visible cervical mass (>2 x 2 cm); (vi) gibbus (sharp 
angular spine deformity); and (vii) other signs suggestive of possible extra-pulmonary TB. 
The clinician also collected histories on feeding practices, prior illnesses (including TB), 
previous use of IPT and other medications, and recorded vaccination history (including BCG 
vaccination), which was verified on the RCH card. All children had chest radiographs taken. 
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Chest X-rays were interpreted by two independent radiologists; in case of discrepancies, a 
third radiologist was asked to resolve the discrepancies. Trained study nurses recorded 
anthropometric measurements, including height and weight, and collected venous blood for 
quantiferon (QFT), full blood counts (FBC), HIV testing, and malaria screening (see also 
“Laboratory Procedures” below). The nurses also performed sputum induction the morning 
after enrollment and collected induced sputum samples for Xpert MTB/RIF (Cepheid; 
Sunnyvale, CA, USA).
20, 21
 
Parents/caregivers were given two pre-labeled containers and were instructed to bring 
urine and stool samples from their children the following day for screening of helminth 
infection. Additionally, each participant was provided with a plastic pocket that had an 
adhesive tape (50 x 20 mm) and a pre-labeled glass slide and asked to submit the slide with 
anal adhesive tape for Enterobius vermicularis examination.
22
 
At 3-Month and 6-Month Follow-Up Visits: Children were clinically evaluated for TB 
and other medical conditions. We collected blood samples for QFT analysis at the 3-month 
visit and for FBC at the 6-month visit. Clinical management was determined based on case 
presentation. 
TB Exposure Score: We used a TB exposure score chart, adopted from South Africa, to 
assess TB exposure.
11
 The chart consists of 10 questions: (i) is the child’s mother the index 
case?; (ii) is the child’s primary caregiver the index case?; (iii) does the child sleep on the 
same bed as the index case?; (iv) does the child sleep in the same room as the index case?; (v) 
is the index case coughing?; (vi) is the index case a pulmonary TB case?; (vii) does the index 
case have smear positive TB?; (viii) does the index case live in the household with the child?; 
(ix) does the index case see the child every day?; and (x) is there more than one TB case in 
the household? Control participants were not assessed for TB exposure. 
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Screening for, and Diagnosing Active TB Disease: We used a comprehensive symptom-
based TB tool to screen for active TB disease at each visit (Table, Supplemental Digital 
Content 3, http://links.lww.com/INF/D203). At baseline, in addition to symptom-based 
screening, we performed chest X-rays and Xpert MTB/RIF for every child within 3 days after 
enrollment
 (see also “Laboratory procedures” below). At follow-up visits, we used the 
symptom-based screening tool; X-ray and/or Xpert MTB/RIF were ordered only if there was 
an indication. Confirmation and final diagnosis were based on clinical evaluation, chest X-ray 
findings and Xpert MTB/RIF, according to Graham et al.
23
 
Children known to have TB exposure but without active disease were started on IPT (20 
mg/kg), in accordance with the Tanzanian NTLP treatment guideline.
12
 Parents/caregivers of 
children with positive QFT results but without documentation of exposure to an infectious 
TB case were counselled and advised to start their children on IPT. Children diagnosed with 
TB were referred to NTLP for TB treatment. All children diagnosed with medical conditions 
were clinically managed in accordance with Tanzanian national guidelines. 
Laboratory Procedures 
Microbiologic Investigations: We performed Xpert MTB/RIF (Cepheid; Sunnyvale, CA, 
USA) on the induced sputum samples
20
 to diagnose active TB disease in the laboratory at 
Temeke district hospital. The laboratory is subject to continuous quality control monitoring 
by the Central Tuberculosis Reference Laboratory (Dar es Salaam, Tanzania). 
QuantiFERON -TB Gold (QFT): We used venous blood to measure M. tuberculosis-
specific T-cell responses, measuring levels of interferon-gamma released in whole blood in 
response to stimulation with the M. tuberculosis-specific antigens. The blood was collected in 
three QFT tubes (Quantiferon-TB Gold, Cellestis; Carnegie, Victoria, Australia): TB-Ag 
(coated with MTB specific antigens), Mitogen (positive control coated with 
phytohaemaggluttin), and Nil (negative control coated with saline). The blood was 
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transferred to the laboratory within 1 hour and incubated at 37ºC for 16–18 hours. After 
incubation, the samples were centrifuged and supernatants stored at -80º C pending further 
processing by ELISA to detect interferon-γ (IFN-γ) response associated with M. tuberculosis 
infection. Results were interpreted according to the manufacturer’s instructions. 
Other Blood Tests: HIV screening was done with Alere Determine HIV-1/2 (Alere; 
Holliston, MA, USA) among children ≥18 months of age, or PCR for children <18 months of 
age. Full blood cell counts were done using a MS4 Vet hematology analyzer (Diamond 
Diagnostics; Holliston, MA, USA). 
Helminth Investigations: Stool and urine samples were examined for helminth 
infections using the Kato-Katz, FLOTAC, Baermann, direct microscopy methods and a point-
of-care circulating cathodic antigen (POC-CCA) urine cassette test for Schistosoma mansoni 
diagnosis, as previously described.
17, 22
 
Definitions 
We recorded clinical data directly onto tablet computers using the open-source software, 
open data kit (ODK; http://opendatakit.org/), and the data management tool, “odk_planner”.24 
The TB exposure score was categorized into not likely to have TB infection (with a score of 
1–6) or presumptive TB infection (score of ≥7). A composite QFT result was defined as 
positive QFT at either baseline or 3-month follow-up. A child was considered TB infected if 
the QFT result was positive. A child was considered to have active TB (probable or possible 
diagnosis) according to international consensus from an expert panel.
25
 Chest radiograph 
features suggestive of TB included consolidation, cavities, and hilar lymphadenopathy. 
Children diagnosed with active TB disease 3 months after enrollment were defined as 
coprevalent TB cases, while children diagnosed with TB 3 months after enrollment were 
defined as incident TB cases.
8
 Anemia was defined as hemoglobin (Hb) <11.0g/dl, as per 
WHO recommendations, further stratified into mild (Hb: 10-10.9 g/dl), moderate (Hb: 7.0-9.9 
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g/dl), and severe anemia (Hb: <7.0 g/dl).
26
 Anthropometric z-scores were calculated using the 
2006 WHO Growth Standards in Stata version 13.1 (Stata Corp. LLC; College Station, TX, 
USA), using the ‘zscore06’ command.27 Helminth infection was defined as infection with any 
of the following helminth species: Ascaris lumbricoides, E. vermicularis, Hymenolepis 
diminuta, hookworm, Schistosoma haematobium, S. mansoni, Strongyloides stercoralis, and 
Trichuris trichiura. 
Statistical Analysis 
Frequencies and proportions were used to describe the children’s demographic and 
clinical characteristics, both overall and stratified according to the presence or absence of 
documented TB exposure. QFT indeterminate results were excluded in the LTBI risk factor 
analysis. We performed mixed logistic regression analyses to identify risk factors for LTBI 
taking into account the matching of TB-exposed and unexposed children. These analyses 
were conducted with and without interaction terms between the respective risk factor 
variables and TB-exposure status. Additionally, we ran stratified analyses separating TB-
exposed and unexposed children. 
We generated an exposure scale based on the TB exposure score (0, no exposure; 1–4, 
minimal exposure; 5–6, medium exposure; and 7–10, maximum exposure). We constructed a 
core multivariable mixed logistic regression model for QFT-conversion and reversion 
between baseline and follow-up, comprising age, sex, and lymphocyte count, and 
alternatively added TB exposure, IPT during follow-up, and helminth infection as potential 
risk factors for QFT conversion and reversion. For children documented to have TB 
exposure, we also added TB exposure score and mother being index case as potential risk 
factors for QFT conversion and reversion. We also presented graphically the paired QFT 
results at enrolment and after 3 months, separately for QFT converters and reverters to 
illustrate the distribution of IFN-γ values during the two visits for children who converted to 
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QFT positive, reverted to QFT negative, and those who did not change. All analyses were 
performed in Stata version 13.1 (Stata Corporation; College Station, TX, USA). 
Ethical Considerations 
The study was approved by the Institutional Review Board of the Ifakara Health Institute 
(IHI; reference no. IHI/IRB/No: 12-2015), the Medical Research Coordinating Committee of 
the National Institute for Medical Research in Tanzania (NIMR; reference no. 
NIMR/HQ/R.8a/Vol. IX/2002), and by the Ethics Committee of the Northwestern and 
Central Switzerland (EKNZ; reference no. UBE-15/49). All children were recruited only after 
their parents/caregivers gave written informed consent. 
RESULTS 
Children’s Baseline Characteristics 
Of the 398 children 6-59 months of age invited to participate in the study, 325 
parents/caregivers provided written informed consent, and hence, their children were 
enrolled. Clinical, demographic, and socioeconomic information were obtained from 316 
children. Fifteen children did not provide blood samples for QFT analysis, thus, 301 children 
were included in the final analysis (Fig., Supplemental Digital Content 1, 
http://links.lww.com/INF/D201). 
Among the 301 child participants, 186 (62%) were exposed to adults with smear-positive 
pulmonary TB, and 115 (38%) were not known to have been exposed to TB. Overall, the 
median age was 26 months (range 6-58 months); 156 (52%) were girls and four were HIV-
positive (Table, Supplemental Digital Content 4, http://links.lww.com/INF/D204). All 
children were BCG vaccinated based on vaccination documents. TB-exposed children were, 
on average, older than children without known TB exposure. Ninety-five (32%) children 
presented with signs and symptoms suggestive of TB (Fig., Supplemental Digital Content 5, 
http://links.lww.com/INF/D205). 
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A total of eight (2.7%) children developed active TB during follow-up (six in the 
exposed, two in the unexposed group). All TB cases were diagnosed based on a clinical case 
definition,
25
 which included patient’s history, chest radiography, positive response to anti-TB 
medication, and evidence of TB infection. Five children (1.7%) were considered co-prevalent 
TB cases (three exposed to infectious TB cases); four of them were <2 years, four were boys, 
and one was HIV-positive. Three children were considered incident TB cases; one was <2 
years, and none was HIV positive. The proportion of children with active TB (prevalent and 
incident) in the exposed and non-exposed group was statistically not significantly different 
(3.2% vs. 1.7%, p=0.44). Children exposed to HIV-seropositive mothers were not more likely 
to have active TB compared with HIV non-exposed children (7% vs. 2%, p=0.15). All 
children with TB had mild or moderate anemia. 
Prevalence of LTBI in TB Exposed and Unexposed Children 
At enrollment, 15% (27/186) of TB exposed children were QFT-positive compared with 
10% (12/115) of children without documented TB exposure (p=0.37). Indeterminate QFT 
results were also equally distributed between the two groups (9/115 [8%] vs. 9/186 [5%], 
p=0.37). At the 3-month follow-up visit (composite results), QFT was positive in 20% 
(61/301) children: 20% (38/186) of TB exposed vs. 20% (23/115) of TB unexposed (p=0.9), 
as shown in Table 1. The prevalence of indeterminate results was 3% (9/301). 
Of those children diagnosed with active TB during follow-up, 10% (4/39) had a positive 
QFT result at enrolment. Among co-prevalent TB cases, 2/5 had positive QFT results, and 
2/3 incident TB cases were QFT positive. 
A fitted model, taking clustering into account, did not suggest any correlation between 
QFT-positive results (indicating LTBI) and the TB exposure score (odds ratio (OR) 1.06, 
95% confidence interval (CI) 0.81-1.40, p=0.7). There was also no correlation between LTBI 
and the presence of a BCG scar; all children had a documented BCG vaccination. 
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Risk Factors for LTBI 
We found that TB-exposed children from households with up to five members had a 
higher risk of having LTBI (defined as a positive QFT test result) compared with all other 
children (OR 3.57, 95% CI 1.54-7.69, p=0.003) (Table 2). All other risk factors such as age, 
sex, lymphocyte count, having a mother with TB, sleeping in the same bed as the index case, 
and household income showed no association. Among children without documented TB 
exposure, none of the risk factors showed significant association with LTBI. 
QFT Conversion, Reversion, and Associated Patient Factors 
Forty-seven (16%) children had different QFT results when retested at the 3-month visit: 
22 (8%) children converted to QFT-positive at the 3-month follow-up, 11 (50%) of which 
had documented TB exposure. Twenty-five children (8%) reverted to negative QFT results at 
the 3-month follow-up. Considering variables such as sex, age category, average BCG scar 
size, lymphocyte counts, an index mother, isoniazid uptake, and infection with any helminth, 
we found none of the factors to be predictive for either QFT conversion or reversion (Table, 
Supplemental Digital Content 6, http://links.lww.com/INF/D206). Neither were coprevalent 
TB cases and incident cases associated with QFT conversion or reversion. Figure 1 shows the 
paired semiquantitative QFT results at enrolment and at the 3 months follow-up visit. 
IPT Uptake among Exposed and Unexposed Children 
By the six-month visit (end of follow-up), 72% (133/186) children exposed to an 
infectious TB case had started IPT (Table 1), and 28% (53/186) did not start IPT. Among the 
53 who did not start IPT, 57% (30/53) parents/caregivers refused IPT, and 43% (21/53) were 
lost to follow-up. Among the 133 children who started IPT, 3% (4/133) developed active TB 
later on (two co-prevalent, two incident cases) and were started on anti-TB medications. Of 
the 53 exposed children who were not started on IPT, 6% (2/53) developed TB disease and 
started anti-TB medications (1 co-prevalent, 1 incident case).  
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Among 115 children with undocumented TB exposure, 20% (23/115) had an LTBI 
diagnosis based on QFT testing. Of these 23 children, one child started IPT, and one child 
developed TB later on (coprevalent case) and was started anti-TB medication; 61% (14/23) of 
parents/caregivers refused IPT; and 30% (7/23) were lost to follow-up. 
DISCUSSION 
We present findings from a prospective study of 186 TB-exposed children 6-59 months 
of age and 115 unexposed controls, who were followed-up for 6 months in the Temeke 
district in Tanzania’s economic capital of Dar es Salaam, characterized by high TB 
notification rate. QFT diagnosed equal proportions of children with LTBI in the two groups. 
IPT uptake was low among TB-exposed children, and even lower among children with 
undocumented TB exposure. 
We showed that, overall, TB infection among exposed children, less than 5 years-old, 
was low, but interestingly similar proportions of children in the two groups (TB-exposed and 
unexposed) were diagnosed with LTBI. The positive QFT results among children that did not 
have known exposure to TB is likely the result of community exposure to infectious TB 
cases. Previous studies have suggested that young children are more likely to be infected in 
domiciliary settings,
28-30
 but due to the high prevalence of the disease in our setting, 
community exposure cannot be ruled out. Our findings show a higher proportion of LTBI 
among TB-unexposed children (20%) compared with other studies that assessed LTBI by 
QFT in under-5 year-old children (range 2.2-17.9%).
31-33
 Previously documented reasons 
associated with LTBI among children include visiting other households and poor ventilation 
in the visited households.
30
 However, our reported proportion of LTBI was considerably 
lower compared with other studies that report LTBI prevalence as high as 49%.
8
 The lower 
LTBI prevalence in our study population may be due to a timely TB diagnosis in index cases, 
resulting in lower risk of transmission. Children from larger households were less likely to 
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have QFT-positive results, indicating lower transmission resulting from less exposure time to 
an infectious TB case.
30
 
Our results suggest that IPT implementation in our study population remains a challenge. 
Indeed, about a third of the children eligible for IPT had not yet started treatment, as 
recommended by WHO in its roadmap for childhood TB.
34
 It should be noted, however that a 
study in India reported a much lower uptake (22%), while more than half of the exposed 
children in our study were on medication.
35
 High-income settings use IGRA for TB 
screening, while many under-resourced settings use symptomatic screening techniques to 
initiate TB preventive therapy, due to high cost of IGRA tests.
8, 10
 The WHO recommends 
IPT in all children below the age of 5 years who are in contact with an infectious TB case or 
with proven TB infection after excluding active disease.
34, 36
 IGRAs could be a useful tool to 
guide delivery of IPT in TB high burden settings, but screening strategy must consider 
transmission dynamics and population characteristic unique to each setting. This policy-
practice gap that exists in high-burden settings needs to be addressed provided resources 
allow. 
Contrary to other studies, our findings show a small proportion of children with 
indeterminate QFT results. The prevalence of indeterminate QFT results varies, especially 
among children.
32, 37-40
 For instance, Italy reported a prevalence of 0.6%, while in South 
Africa, a prevalence of 2.5% was found. Compared with those two countries, our prevalence 
was considerably higher.
8, 32
 Malnutrition, helminth infection, and HIV infection are 
reportedly associated with indeterminate QFT results.
38, 40
 However, in our study population, 
the proportion of indeterminate results was low even after repeating the test at the 3-month 
follow-up visit and considering composite QFT results, which we used to define the final 
results. Contrary to other studies, we did not find any association between indeterminate QFT 
results and helminths.
38
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Overall, a low proportion of children had active TB disease at the end-of-follow-up visit. 
Despite the high risk of disease progression in young children after TB infection, the number 
of children developing active TB disease in our cohort was very low compared with those in 
Italy, where 5% of children developed active TB disease.
32
 The majority of children 
diagnosed with active TB did not have radiologic findings consistent with active TB disease. 
This might be explained by a mild form of the disease diagnosed during presentation. 
However, in children, absence of radiologic findings can be explained by transient radiologic 
changes and the natural history of primary TB complex, which self-cures without 
intervention.
2
 Due to the low number of incident cases, we did not find sufficient evidence 
for risk factors associated with active disease. Despite systematic and thorough screening of 
active TB disease, none of the TB cases, neither coprevalent nor incident TB cases, were 
microbacteriologically confirmed with Xpert MTB/RIF. Although this may be due to the 
paucibacillary nature of childhood TB, this finding may also reflect early diagnosis of the 
disease at presentation in our study. 
Our study has strengths and limitations to be considered. We encountered a few 
challenges, mainly during enrollment, that are worth highlighting. Several parents/caregivers, 
especially those whose children had no history of TB exposure, were reluctant to subject their 
children for screening and were concerned with the sputum induction procedure despite 
intensive counseling. All children were systematically screened for TB, HIV, malaria, and 
helminth infection, as all of these diseases contribute to morbidity and mortality in this age-
group. 
In conclusion, our findings suggest that non-household transmission of TB occurs at 
significant rates and warrants consideration of screening among young children in high TB 
incidence countries. Similar to many other settings, IPT uptake among children exposed to an 
infectious TB case is far below the global target of 90%, as set by WHO. Contact tracing of 
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young children remains an important strategy to prevent active TB disease. To attain this, a 
road map to zero TB deaths among children emphasizes, among other issues, the collective 
responsibility of the health system, greater awareness among healthcare providers, and 
increased childhood TB screening.
34
 Integrating routine pediatric TB screening with child 
health clinics will enhance awareness to the community and advocate for early screening 
among young children suspected to have TB.
41-43
 In TB-endemic settings where TB exposure 
in the community is high, strategies to evaluate TB infection should not be limited to child 
contacts only. 
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Figure legends 
Figure 1: Trends in the distribution of semiquantitative quantiferon (QFT) results (IFN-γ 
values) among 226 children 6-59 months of age at recruitment and at the 3-month follow-up 
visit in Temeke district, Dar es Salaam, Tanzania between October 2015 and September 2016 
 
Supplementary Digital Content legend 
Supplementary Digital Content 1. (figure) Selection of study participants and blood 
samples. 
Supplementary Digital Content 2. (text) Standard Operating Procedure: Control child 
invitation 
Supplementary Digital Content 3. (table) TB screening tool 
Supplemental Digital Content 4. (table) Baseline demographic, socioeconomic and clinical 
characteristics of 301 children under the age of 5 years, enrolled between October 2015 and 
September 2016, and their parents/caregivers in Temeke district, Dar es Salaam, Tanzania. 
Supplemental Digital Content 5. (figure) Screening algorithm and diagnosis of TB among 
enrolled children 
Supplemental Digital Content 6. (table) Determinants of quantiferon (QFT) conversion and 
reversion at three-month follow-up visit among under-fives in Dar es Salaam, Tanzania 
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Table 1. Prevalence of latent tuberculosis infection (LTBI) based on composite quantiferon (QFT) results among children aged below 
5-years in Temeke, Dar es Salaam, Tanzania enrolled between October 2015 and September 2016. 
 
Characteristics 
TB exposed (n=186)  TB unexposed (n=115) 
QFT result   QFT result 
Positive Negative Indetermin
ate 
  Positive Negative Indetermin
ate Total n (%) 38 (20) 144 (78) 4 (2)  23 (20) 87 (76) 5 (4) 
Age (months), median (IQR) 33 (22-43) 26 (17-
44) 
29 (13-47) 
 
26 (17-43) 24 (12-37) 20 (18-34) 
Age groups (months)        
6-23 12 (32) 59 (41) 2 (50)  10 (43) 43 (491) 3 (60) 
24-59 26 (68) 85 (59) 2 (50)  13 (57) 44 (51) 2 (40) 
Female 26 (68) 77 (53) 1 (25)  12 (52) 38 (44) 2 (40) 
BCG scar diameter (mm)        
No scar 9 (24) 29 (20) 2 (50)  1 (4) 9 (10) 0 
1-4 16 (42) 71 (49) 2 (50)  14 (61) 46 (53) 4 (80) 
>4 13 (34) 44 (31) 0  8(35) 32 (37) 1 (20) 
HIV positive 0 2 (1.4) 0  1 (4) 1 (1.2) 0 
>3people in the sleeping 
room 
10 (26) 31 (22) 2 (50)  5 (22) 20 (23) 1 (20) 
M ther index 
1
 15 (39) 39 (27) 0     
Index other primary 
caregiver 
1
 
9 (24) 33 (23) 3 (75)  - - - 
Sle p same bed as index 
1
 28 (74) 87 (60) 3 (75)  - - - 
Multiple indexes in h/hold 
1
 5 (13) 13 (9) 0  - - - 
Likely infected with TB 
1
 25 (66) 82 (57) 3 (75)  - - - 
Coprevalent TB cases 
2
 1 (3) 2 (1.4) 0  1 (4) 1 (1.2) 0 
Incident TB cases 
3
 2 (5) 1 (0.7) 0  0 0 0 
IPT during follow-up 29 (76) 101 (70) 3 (75)  1 (4) 0 0 
Any helminth infection 10 (26) 32 (22) 2 (50)  8 (35) 17 (20) 1 (20) 
LTBI defined as positive QuantiFERON-TB-Gold at either baseline or 3-month follow-up (composite QFT result). Children who 
developed TB during follow-up are included in this analysis. 
IPT, isoniazid prophylactic therapy; QFT, quantiferon; LTBI, latent tuberculosis infection; TB, tuberculosis 
1
 Applicable to TB-exposed group only based on TB exposure score based on Mandalakas et. al. [11] 
2 
Diagnosed within 3 months of enrollment 
3
 Diagnosed after 3 months post enrollment  
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Table 2. Risk factors for LTBI among children aged below 5 year in Temeke, Dar es Salaam, Tanzania. 
 
Characteristics 
n (%) 
All 
292 
TB exposed (n=182)  TB unexposed (n=110) 
OR (95% CI) p value  OR (95% CI) p value 
Age groups (months)   0.29   0.61 
6-23 124 (42) 1   1  
24-59 168 (58) 1.50 (0.70-3.22)   1.27 (0.51-3.21)  
Sex   0.10   0.47 
Male 139 (48) 1   1  
Female 153 (52) 1.89 (0.88-4.02)   1.41 (0.56-3.52)  
BCG scar diameter (mm)   0.63   0.39 
No scar 48 (16) 1   1  
1-10 244 (84) 0.81 (0.34-1.90)   2.54 (0.30-21.13)  
HAZ   0.36   0.49 
Normal 231 (79) 1   1  
Stunted 61 (21) 1.48 (0.64-3.40)   1.45 (0.50-4.24)  
TB clinical sign and symptoms   0.22   0.11 
None 143 (49) 1   1  
At least one 149 (51) 1.58 (0.76-3.26)   0.45 (0.17-1.18)  
Hemoglobin level (g/dl)   0.17   0.48 
Not anemic ≥11.5 99 (34) 1   1  
Anemic <11.5 189 (65) 0.60 (0.29-1.24)   0.71 (0.27-1.84)  
Lymphocyte count
2
   0.33   0.24 
Normal 226 (77) 1   1  
Abnormal 66 (23) 0.60 (0.22-1.67)   1.79 (0.68-4.69)  
Any helminth infection   0.59   0.13 
Negative 225 (77) 1   1  
Positive 67 (23) 1.25 (0.55-2.84)   2.20 (0.80-6.02)  
Mother index case
1
   0.14   - 
No 238 (82) 1   -  
Yes 54 (18) 1.76 (0.83-3.71)   -  
Sleep same bed as index case
1
   0.13   - 
No 177 (61) 1   -  
Yes 115 (39) 1.83 (0.83-4.06)   -  
Household income per month 
(USD) 
  0.36   0.19 
<100 105 (36) 1   1  
≥100 187 (64) 1.41 (0.67-2.98)   0.53 (0.20-1.38)  AC
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Household size   0.003   0.25 
>5 people 121 (40)  1   1  
1-5 person 173 (60) 3.57 (1.54-7.69)   2.86 (0.64-5.6)  
Nine children with indeterminate QFT results were excluded in this analysis. LTBI was defined as a positive QuantiFERON-TB-Gold 
(QFT) test at either baseline or 3-month follow-up. 
H/hold, household; HIV, human immunodeficiency virus; USD, United States dollars (1 USD=2,190 Tanzanian shillings) 
Estimates derived from bivariate mixed logistic regression models. 
1 
Applicable to TB-exposed group only based on TB exposure score based on Mandalakas et al. [11] 
2
 Lymphocytes, normal 2.1-9.5, abnormal <2.1 or >9.5 10
3/μl 
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Figure 1 
 
 
 
 
Dashed lines represent cut off  -1.05 
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